Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on: May 06,2024 11

Model suggests increased use of Paxlovid could cut hospitalizations, deaths and costs

by University of Texas at AustinEpidemiology researchers have found that if just 20% of symptomatic COVID cases was treated with Paxlovid, it would reduce deaths, hospitalizations and costs. Cred

Updated on:May 06,2024 11

Harnessing Digital Medicine to Enhance CAR-T Cell Therapy: A Convergence of Frontiers

Updated on: July 21,2025 0

Harnessing Digital Medicine to Enhance CAR-T Cell Therapy: A Convergence of Frontiers

Updated on:July 21,2025 0

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on: January 08,2024 9

Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAmong individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for h

Updated on:January 08,2024 9

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on: January 23,2024 14

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on:January 23,2024 14

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on: January 11,2024 15

New patient guidelines for marginal zone lymphoma help caregivers better understand a rare form of blood cancer

by National Comprehensive Cancer NetworkNCCN Guidelines for Patients: Marginal Zone Lymphoma now available for free at NCCN.org/patientinformation. Credit: NCCNThe National Comprehensive Cancer Networ

Updated on:January 11,2024 15

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on: April 12,2024 16

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e

Updated on:April 12,2024 16

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on: January 02,2024 9

How to lower your risk of breast cancer recurrence

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainMost women treated for breast cancer have something else in common: they worry about the cancer coming back.

Updated on:January 02,2024 9

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on: January 02,2024 10

US Preventive Services Task Force: Evidence still lacking for routine skin cancer screening

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is currently insufficient for assessing the balance of benefits and harms of screening asymptomatic adolescents and adults

Updated on:January 02,2024 10

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on: January 15,2024 19

New therapy harnesses patients' blood cells to fight tumors

by Win Reynolds,Northwestern UniversityCredit: CC0 Public DomainAdoptive cell therapy (ACT) has become a promising immunotherapy tool to help treat advanced melanoma. The therapy, which harnesse

Updated on:January 15,2024 19

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on: February 03,2024 15

Research is uncovering new ways to treat an aggressive brain cancer

by Anthony King,Horizon: The EU Research & Innovation MagazineCredit: AI-generated imageBrain surgeons need steady hands as well as cool heads. Now they're getting a helping hand from re

Updated on:February 03,2024 15

Researchers identify a better biomarker for an aggressive and fatal liver cancer

by Ryn Thorn,Medical University of South CarolinaDr. Anand Mehta (left) and Dr. Shaaron Ochoa-Rios (right) in the Mehta laboratory at the Medical University of South Carolina. Credit: Medical Un

Updated on: February 18,2024 11

Researchers identify a better biomarker for an aggressive and fatal liver cancer

by Ryn Thorn,Medical University of South CarolinaDr. Anand Mehta (left) and Dr. Shaaron Ochoa-Rios (right) in the Mehta laboratory at the Medical University of South Carolina. Credit: Medical Un

Updated on:February 18,2024 11

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on: April 09,2024 18

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on:April 09,2024 18